These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35071159)

  • 1. Socio-Demographic Characteristics of COVID-19 Vaccine Recipients in Kwara State, North Central Nigeria.
    Al-Mustapha AI; Abubakar MI; Oyewo M; Esighetti RE; Ogundijo OA; Bolanle LD; Fakayode OE; Olugbon AS; Oguntoye M; Elelu N
    Front Public Health; 2021; 9():773998. PubMed ID: 35071159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national survey of COVID-19 vaccine acceptance in Nigeria.
    Al-Mustapha AI; Okechukwu O; Olayinka A; Muhammed OR; Oyewo M; Owoicho SA; Abubakar AT; Olabisi A; Jibril A; Ereh S; Fakayode OE; Ogundijo OA; Elelu N; Adetunji VO
    Vaccine; 2022 Aug; 40(33):4726-4731. PubMed ID: 35764433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-level survey of coronavirus disease 2019 (COVID-19) preventive measures in Kwara State, Nigeria: good knowledge vs poor attitude.
    Elelu N; Bilewu O; Sanusi F; Al-Mustapha AI
    Glob Health J; 2022 Sep; 6(3):168-173. PubMed ID: 35818517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Events Following COVID-19 Vaccination in Rivers State, Nigeria: A Cross-Sectional Study.
    Harry AM; Edet CK; Ekanem NE; Kemdirim CJ; Uduak AE
    Niger Postgrad Med J; 2022; 29(2):89-95. PubMed ID: 35488575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking Side Effects of the COVID-19 Vaccine in Mymensingh District of Bangladesh.
    Khan MK; Ferdous J; Akhter S; Esha AM; Islam M
    Mymensingh Med J; 2022 Jan; 31(1):1-9. PubMed ID: 34999672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptance of COVID-19 vaccines in sub-Saharan Africa: evidence from six national phone surveys.
    Kanyanda S; Markhof Y; Wollburg P; Zezza A
    BMJ Open; 2021 Dec; 11(12):e055159. PubMed ID: 34911723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review.
    Joshi A; Kaur M; Kaur R; Grover A; Nash D; El-Mohandes A
    Front Public Health; 2021; 9():698111. PubMed ID: 34485229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh.
    Mahmud S; Mohsin M; Khan IA; Mian AU; Zaman MA
    PLoS One; 2021; 16(9):e0257096. PubMed ID: 34499673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caregivers' Willingness to Accept Expedited Vaccine Research During the COVID-19 Pandemic: A Cross-sectional Survey.
    Goldman RD; Marneni SR; Seiler M; Brown JC; Klein EJ; Cotanda CP; Gelernter R; Yan TD; Hoeffe J; Davis AL; Griffiths MA; Hall JE; Gualco G; Mater A; Manzano S; Thompson GC; Ahmed S; Ali S; Shimizu N;
    Clin Ther; 2020 Nov; 42(11):2124-2133. PubMed ID: 33067013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socio-Demographics Correlate of COVID-19 Vaccine Hesitancy During the Second Wave of COVID-19 Pandemic: A Cross-Sectional Web-Based Survey in Saudi Arabia.
    Al-Mohaithef M; Padhi BK; Ennaceur S
    Front Public Health; 2021; 9():698106. PubMed ID: 34249851
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
    Akyala AI; Iwu CJ
    Pan Afr Med J; 2020; 37():47. PubMed ID: 33209174
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Iliyasu Z; Garba RM; Aliyu MA; Gajida AU; Amole TG; Umar AA; Abdullahi HM; Tsiga-Ahmed FI; Kwaku AA; Kowalski MS; Salihu HM; Aliyu MH
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 impact on Nigeria's national blood service commission - Lessons for Low- and Middle-Income Countries (LMICs).
    Oreh AC; Irechukwu C; Biyama F; Nnabuihe A; Ihimekpen A; Oshiame D; Bozegha T; Leo-Nnadi I; Izedonmwen O; Oga E; Suberu EJ; Odiabara K; Amedu OJ
    Niger Postgrad Med J; 2022; 29(1):6-12. PubMed ID: 35102944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccination acceptance in the canton of Geneva: a cross-sectional population-based study.
    Wisniak A; Baysson H; Pullen N; Nehme M; Pennacchio F; Zaballa ME; Guessous I; Stringhini S;
    Swiss Med Wkly; 2021 Dec; 151():w30080. PubMed ID: 34908389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
    Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
    JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.
    Reuken PA; Albers S; Rauchfuss F; Strnad P; Settmacher U; Trautwein C; Stallmach A; Bruns T
    Z Gastroenterol; 2021 Dec; 59(12):1288-1296. PubMed ID: 34670294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.